Archer Aviation Posts Wider Loss but Secures FAA Milestone and Record Liquidity

What happened

Archer Aviation reported a wider-than-expected fourth-quarter loss for 2025, reflecting persistent high cash burn as it pushes toward eVTOL certification. The company ended the fiscal year with $1.96 billion in liquidity, bolstered by a recent $650 million equity raise, which provides a substantial funding runway amid heavy spending. A key regulatory advance was achieved with 100% FAA acceptance of Midnight's Means of Compliance, positioning Archer ahead of peers in certification progress. However, aggressive R&D expenditures of $493.9 million and significant stock-based compensation underscore ongoing dilution risks, amplified by an authorized share increase to 1.71 billion. Overall, while liquidity and FAA progress offer short-term reassurance, Archer remains pre-revenue with commercialization timelines dependent on FAA and UAE approvals, leaving it vulnerable to further equity issuance if milestones slip.

Implication

The record liquidity reduces near-term insolvency risk, yet it stems from equity raises that expand dilution capacity, capping upside potential. FAA acceptance is a positive step but does not guarantee timely UAE certification, which remains tied to FAA maturity and could push revenue timelines. Without disclosed Omen powertrain pricing or delivery schedules, Archer lacks a clear revenue bridge to offset cash burn and reduce reliance on equity markets. Heavy spending on R&D and stock-based compensation signals management's aggressive push but also heightens per-share value erosion if commercialization falters. Consequently, investors should await concrete evidence from upcoming filings on Omen monetization and regulatory milestones before considering entry, as dilution risk overshadows operational progress.

Thesis delta

The new data reinforces Archer's cash-intensive model and regulatory advances but does not shift the core 'WAIT' thesis, as the Omen powertrain revenue bridge remains unquantified. Liquidity improvement mitigates immediate funding concerns, yet dilution overhang persists due to expanded share authorization and ongoing losses. Thus, the investment call stays unchanged, pending disclosures on Omen economics and UAE certification timelines within the next 3-6 months.